Skip to content
healthcare.dev

AMPHADASE

NDC 0548-9090, hyaluronidase, injection, from Amphastar Pharmaceuticals, Inc..

Product NDC
0548-9090
Status
Listed
Labeler
Amphastar Pharmaceuticals, Inc.
Dosage form
INJECTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA021665
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0548-9090 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HYALURONIDASE150 [USP'U]/mL

Pharmacologic classes

Endoglycosidase [EPC]; Glycoside Hydrolases [CS]

Package NDCNDC-11Package
0548-9090-100054890901010 VIAL, SINGLE-DOSE in 1 CARTON (0548-9090-10) / 1 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/8396ea96-7cb5-4e26-87a4-90bca9c3c6dd
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0548-9090

Use it

Look up 0548-9090 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0548-9090 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0548-9090. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.